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Zinc ions serve as second messengers in major cellular pathways, including the regulation pathways of proliferation and their proper regulation is necessary
for homeostasis and a healthy organism. Accordingly, expression of zinc transporters can be altered in various cancer cell lines and is often involved in producing
elevated intracellular zinc levels. In this study, human B cells were infected with Epstein–Barr virus (EBV) to generate immortalized cells, which revealed traits of
tumor cells, such as high proliferation rates and an extended lifespan. These cells showed differentially altered zinc transporter expression with ZIP7 RNA and
protein expression being especially increased as well as a corresponding increased phosphorylation of ZIP7 in EBV-transformed B cells. Accordingly, free zinc
levels were elevated within these cells. To prove whether the observed changes resulted from immortalization or rather high proliferation, free zinc levels in in
vitro activated B cells and in freshly isolated B cells expressing the activation marker CD69 were determined. Here, comparatively increased zinc levels were
found, suggesting that activation and proliferation, but not immortalization, act as crucial factors for the elevation of intracellular free zinc.
© 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Zinc is an essential trace element and fulﬁlls numerous functions in
the human body. Since zinc deﬁciencywas conﬁrmed in 1963 to cause
severe effects in humans [1], various researchers have centered their
interest on the study of zinc and its effects.
The importance of zinc is described especially for the immune
system [2]. Both, innate and adaptive immunity, rely on the accurate
concentration of zinc and regulation of zinc transporters to ensure zinc
homeostasis [3]. Zinc deﬁciency severely affects the immune system, as
impressively shown in acrodermatitis enteropathica, an inherited
disorderwith a loss-of-functionmutation of ZIP4which is accompanied
by zinc deﬁciency [4]. In this study, we examined B cells, whose correct
function is indispensable for the human immune system. B cells are
antigen-presenting cells, which produce antibodies and cytokines,
represent the immunological memory and even seem to have
regulatory and suppressing functions in inﬂammation [5]. In mice,
dietary zinc deﬁciency leads to lymphopenia by loss of precursor B cells
[6]. In addition, zinc deﬁciency reduces T cell-dependent antibody☆ Declarations of interest: none.
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on T cell functions, the B cell system is also affected by zinc deﬁciency.
The total amount of zinc in a human body is about 2–3 g with the
highest concentrations in bone, prostate and pancreatic tissue [7].
Many physiological functions are dependent on zinc, because it
performs catalytical and structural roles within enzymes [8]. More
than 3000 proteins are estimated to have a zinc binding motif,
including metalloenzymes and transcription factors like zinc ﬁnger
proteins [9]. These proteins buffer most intracellular zinc with high
afﬁnity [10]. However, a signiﬁcantly smaller pool of zinc ions exists in
a “free” or “labile” intracellular form [11]. In this manuscript, the term
“free”will be used for these ions. In fact, the free zinc can also be bound
slightly to organic and inorganic lowmolecularweightmolecules [12].
The concentration of zinc ions in this pool ranges from high picomolar
to low nanomolar [13]. Free zinc ions can induce effects in cells as
second messengers in various signaling pathways [2,14]. Hence, a
strict control of homeostasis and ﬂuctuations of the small zinc pool is
necessary at the cellular level to prevent unwanted signaling.
24 known zinc transporters regulate intracellular zinc levels by
carrying zinc ions across biological membranes [14–16]. In detail, the
zinc transporters belong to two families, 14 human Zrt-/Irt-like proteins
or solute carriers 39A (ZIP/SLC39A) and 10 zinc transporters or solute
carriers 30A (ZnT/SLC30A) are known so far. ZIPs are zinc importers,
which transport zinc ions into the cytoplasm, either from the outside of
a cell or from an intracellular compartment. ZnTs, in contrast, are
exporters, which facilitate zinc efﬂux out of the cell and into
intracellular organelles and storage systems [17]. Current knowledgeer the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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has been reviewed in detail elsewhere [14–17].
Apart from other effects, zinc ions promote proliferation via major
protein kinase pathways such as the phosphatidylinositide 3-kinase
(PI3K)/AKT cascade or the extracellular signal-regulated kinase (ERK)
pathway [18–20], especially downstream of a ZIP7-mediated zinc store
release [21]. Cell proliferation is pivotal, but uncontrolled proliferation,
e.g. via hyperactivation of these proliferation-promoting signaling
molecules, leads to great damage and is a common phenomenon in
cancer [22]. In recent years, altered intracellular zinc homeostasis
and expression of zinc transporters has been found in various cancer
cells [23–25]. Common characteristics of malignant cells are abnormal
regulation processes, resulting in autonomous growth, increased lifespan
[26] and suppression of apoptosis [27]. Suppressed apoptosis allows
mutated cells to survive, to accumulate mutations without being
eliminated and to gain malignancy [27]. In addition to its role in
proliferation pathways, zinc inhibits pro-apoptotic enzymes like caspases
and, thus, prevents apoptosis [28–30]. However, both, very high and low
zinc levels, can initiate cell death via different pathways [31,32].
For example, higher zinc supply by overexpression of the zinc
importer ZIP4 in pancreatic cancer cells is suggested to be associated
with higher proliferation rates and tumor progression via phosphoryla-
tion of a zinc ﬁnger transcription factor and subsequent acceleration
of the cell cycle creatinghigher cell proliferation [33].Moreover, this zinc
importer seems to be involved in the regulation of matrix metallopro-
teinases (MMP), neuropilin-1 (NRP-1) and its ligandvascular endothelial
growth factor (VEGF). These molecules are known to increase a tumor's
malignancy by enhanced angiogenesis, invasion or metastasis [34].
Theaimof this studywas todetermine the effects of proliferation and
immortalization of B cells on the concentration of free intracellular zinc
and expression of the 24 known zinc transporters at the RNA level.
Immortal B cells were gained by in vitro infection and transformation of
healthy, freshly isolated B cells with EBV, thus, generating lympho-
blastoid cell lines (LCL). In their lymphoblastoid form, B cells are known
to be larger and activated, which is consistent with the production of
certain viral products and rapid proliferation [35]. However, EBV does
not only transformB cells into immortal lymphoblastoid cells in vitro but
it is also associated with cancer development in vivo. Hodgkin
lymphomas, some non-Hodgkin lymphomas, comprising the endemic
Burkitt lymphoma, and tumors, like the nasopharyngeal carcinoma and
some gastric carcinomas, are all known to be partially associated with
EBV infection [36].
An increased intracellular free zinc level was found in the LCL,
consistentwith overexpression of ZIP7 RNA and protein. Furthermore,
an increased phosphorylation of ZIP7 protein was observed, which
implies an activating post-translational modiﬁcation on ZIP7. Other
activated B cells, like in vitro generated activated B cells and in vivo
activated and freshly isolatedB cells,were examinedaswell to exclude
further inﬂuencing factors. The latter were generated by in vitro CD40
ligand (CD40L)-CD40 ligation. Activation was determined by the
expression of the activation marker CD69.
The observed increased amounts of ZIP7 protein and its increased
phosphorylation could also be conﬁrmed in these in vitro generated
activated B cells. Both, in vitro generated activated B cells and freshly
isolated CD69+B cells showed accordingly elevated levels of free zinc,
which is why activation and proliferation, involving an expression of
CD69 in B cells, were assumed to be the determining factors for the
observed changes.
2. Materials and methods
2.1. Isolation of human peripheral blood mononuclear cells (PBMC)
Samples of lithium-heparinized peripheral venous blood of healthy donors, aged
between 20 and 28 years, were diluted with equal amounts of PBS (Sigma-Aldrich,
Germany) at room temperature. PBMCwere isolated by density gradient centrifugationover Biocoll separating solution (Biochrom, Germany, density of 1.077 g/mL) and were
collected from the interface, washed thrice with PBS and resuspended in the required
medium as described below.
2.2. Cell culture
EBV-transformed B cells were grown in IMDM medium and Raji cells in RPMI 1640
medium (both Sigma-Aldrich, Germany). Both media were supplemented with 10% FCS
(PAA, Germany), 2mML-glutamine, 100U/mLpenicillin and 100 μg/mL streptomycin (all
from Sigma-Aldrich, Germany). The adherent murine ﬁbroblast CD40 ligand (CD40L)-
transformed NIH/3T3 cells, kindly provided by Dr. Gordon Freeman (DFCI, Boston, MA,
USA), were grown in DMEM-Ham's/F12 medium supplemented with 10% FCS, 4 mM
L-glutamine, 100U/mLpenicillin, 100 μg/mL streptomycin and10mM4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES). All cells were cultured at 37 °C in a humidiﬁed
5% CO2 atmosphere.
2.3. EBV-transformation
1x107 cells/mL of freshly isolated PBMC in RPMI 1640 medium enriched with 2%
FCS were incubated for 15 min at room temperature in a 1:1 ratio with lysosomotropic
L-leucine methyl ester hydrochloride G-2550 (H-Leu-Leu-OMe · HBr from Bachem,
Switzerland, 0.085 mg/mL in RPMI 1640 medium) to deplete lysosome-rich cells and
allow an undisturbed clonal growth of transformed B cells [37]. The cells were washed
thrice with RPMI 1640 medium enriched with 2% FCS, resuspended in EBV-containing
supernatant of B95–8 cells and split into portions of 1.5mL in 6well plates. 1.5mL IMDM
with the above-mentioned supplements were added to each well after incubation of
two hours at 37 °C and 5% CO2. Cells were subsequently incubated overnight, collected
the next day, washed and counted with trypan blue (Sigma-Aldrich, Germany) staining
to adjust them to 6x105 living cells/mL. When transformed cells and clusters were
microscopically found, cells were split (1:1 with fresh IMDM) and grown in ﬂasks
(1x106/mL). Cells were split twice per week and approximately 20 days later the
following measurements were performed.
2.4. Activation of B cells by murine CD40 ligand transfected (tCD40L) NIH/3T3 cells
ActivationofB cellswasperformedaspreviouslydescribedbyFreemanet al. [38]with
small modiﬁcations to the instruction by Liebig et al. [39], as FCS was used instead of FBS
and human serum, and a combination of 100U/mL penicillin and 100 μg/mL streptomycin
instead of gentamycin. Human insulin (Insuman Rapid) was purchased from Sanoﬁ
(France) and human recombinant transferrin from Sigma-Aldrich (Germany).
2.5. Flow cytometric measurement of free intracellular zinc ions in B cells
2x106 cells were loaded with the ﬂuorescent membrane-permeable probe FluoZin3-
acetoxymethyl ester (AM) (1 μM, Invitrogen,Germany) inmeasurement buffer [40] for 30
min at 37 °C. The membrane permeability of FluoZin3-AM is provided by the
acetoxymethyl ester, whose non-polarity enables the probe to cross membranes. Once
invaded in the intracellular space the ester is degraded rapidly and the probe is trapped
[13]. Afterwards, cells were washedwith and resuspended in 100 μL measurement buffer
and stained with either 4 μL anti-CD19-phycoerythrin (PE), or anti-IgG1-PE as isotype
control. 10 μL anti-CD69-allophycocyanin (APC), or anti-IgG1-APC were added for the
measurement of free intracellular zinc in CD19+ activated B cells (all antibodies
were purchased from BD Biosciences, Germany). After incubation for 20 min at room
temperature in the dark, cells were washed again and resuspended in 1mLmeasurement
buffer and distributed to three tubes. Cells were incubated for 10 min at 37 °C with
either no addition, 50 μM of the membrane-permeant chelator N,N,N′,N′-tetrakis(2-
pyridylmethyl)ethane-1,2-diamine (TPEN) (Sigma-Aldrich, Germany) for determination
ofminimal ﬂuorescence (Fmin) or combination of 100 μMZnSO4 and 10 μMof the ionophore
pyrithione (Sigma-Aldrich, Germany) for determination of themaximal ﬂuorescence (Fmax).
Subsequentmeasurements were performedwith a FACSCalibur (BD Biosciences, Germany).
The concentration of free intracellular zinc was calculated as described before [41] using a
dissociation constant (KD) with 8.9 nM of the FluoZin3/Zn2+ complex [13].
2.6. Flow cytometric measurement of the activation status of B cells
1x106 cells were incubated for 20 min at room temperature in the dark with either
4 μL anti-CD19-PE and 10 μL anti-CD69-APC in 100 μL PBS supplemented with 1% FCS or
4 μL anti-IgG1-PE and 10 μL anti-IgG1-APC. Cells were washed and resuspended in
500 μL PBSwith 1% FCS. Fluorescencemeasurementswere performedwith FACSCalibur.
2.7. RNA isolation and quantitative real time polymerase chain reaction (qRT-PCR)
1x107 cells were resuspended in 1 mL TRI Reagent Solution (Ambion Life
Technologies, Germany) and RNA was extracted following the manufacturer's
instructions. qScript cDNA Synthesis Kit (Quanta Biosciences, Germany) was used for
cDNA transcription according to the manufacturer's manual. qRT-PCR was performed
with a StepOnePlus Real-Time PCR System (Applied Biosystems, Germany) with 5 μL
irradiated water (H2O), 12.5 μL SYBR Green PCR Master Mix (Applied Biosystems,
Germany), 5 μL cDNA, and the respective forward and reverse primers, 1.25 μL (2 μM)
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40 cycles of denaturation for 15 s at 95 °C and annealing/elongation for 30 s at 60 °C (for
ZnT10 at 65 °C). Expression of ZIP1–3 [42], ZIP4–14 [43], ZnT1–9 [44], ZnT10 (forward
CAC CCA GAA TGAGCC AGAAGA C and reverse GAT AAG CGGGAAGGC AGA TGA C) and
porphobilinogen deaminase (PBGD) [45] was analyzed. Presented is the relative
expression of RNA in LCL after EBV-transformation, normalized to the housekeeping
gene PBGD. To allow apresentation of the data of transporters thatwere not determined
before cycle 40, their expression level was set to cycle 40. The ΔΔCT-method was
performed to compare the transporters' expression in the B cell enriched PBMC before
transformation with the expression in LCL. RNA samples were measured with and
without addition of H-Leu-Leu-OMe · HBr to exclude interference of this reagent with
the RNA (data not shown).2.8. Western blot analysis of ZIP7 protein and phosphorylated (p)ZIP7 protein
Cells were lysed by sonication using a Vibra Cell sonicator (Sonics &Materials, USA)
and heated for 5 min at 95 °C. An equivalent of 3x106 cells per lane was separated at
170 V on 10% polyacrylamide gels. After separation, samples were blotted onto
nitrocellulose membranes (GE Healthcare Life Sciences, Germany). Uniform loading of
gels was conﬁrmed by Ponceau S (AppliChem, Germany) staining. Subsequently,
membranes were blocked for 1 h with TBS-T (20 mM Tris–HCl [pH 7.6], 137 mM NaCl,
0.1% [v/v] Tween 20), containing 5% fat-free dry milk, and were washed afterwards
thrice with TBS-T. Incubation with primarymouse monoclonal pZIP7 (S275/S276) [21],
ZIP7 (ProteinTech, United Kingdom) and β-actin (Cell Signaling Technology, Germany)
antibodies was performed overnight at 4 °C at 1/1000 dilution in TBS-T, containing 5%
BSA. Afterwards, membranes were washed thrice with TBS-T and incubated with either
anti-rabbit-HRP (for β-actin and ZIP7) or anti-mouse-HRP (for pZIP7) (both from Cell
Signaling Technology, Germany) secondary antibodies 1/2000 in TBS-T with 5% fat-free
drymilk. After againwashing thricewith TBS-T, immunodetectionwas performed using
LumiGlo Reagent (Cell Signaling Technology, Germany) on LAS-3000 (Fujiﬁlm
Lifescience, Germany). Band density was determined with ImageJ software (NIH, USA).2.9. Statistical analysis
Statistical analyses were performed with GraphPad Prism software (La Jolla, USA).
The Student's t-test and repeated measurement ANOVA with Bonferroni's multiple
comparison test were applied.Fig. 1. Intracellular zinc concentration in B cells before and after transformation and in Raji
of T cells, CD19+ PBMC after T cell depletion and in CD19+ transformed B cells (LCL). No diffe
seen. The LCL show signiﬁcantly higher intracellular zinc levels than non-transformed B cells (
points after transformation (day 0) and following up at day 7 and day 14 to provewhether the e
94 days after transformation. The second and third controls were performed each oneweek late
between the ﬁrst and the fourth day after splitting of the cells and addition of fresh medium
presented. Means sharing the same letter are not signiﬁcantly different from each other (p b 0.0
B). Nonsigniﬁcant differences between means are marked with ns (p N 0.05, Student’s t test fo3. Results
3.1. Increased free zinc levels were found in human B cells upon
EBV-transformation
In vitro EBV-infection of B cells gives rise to lymphoblastoid cells,
which is called transformation or immortalization. CD19 is a surface
protein that is expressed exclusively on the cell surface of the B cells
and co-ligates with the B cell receptor [46]. In this study CD19 was
used to identify B cells. The concentration of free zinc in CD19+ cells
was signiﬁcantly increased in the LCL compared to non-transformed B
cells (Fig. 1A). The free zinc level in PBMC was not affected by H-Leu-
Leu-OMe · HBr, which was used for T cell depletion (Fig. 1A). The
elevated zinc level in the LCL did not decrease during long term
culturing, as repeated control measurements conﬁrmed (Fig. 1B). To
exclude culture conditions as a reason of changes in intracellular zinc
levels, the zinc concentration was measured in Raji cells at different
timepoints after subculture (Fig. 1C). In 1963, the Raji B cell line was
derived fromanAfrican EBV+Burkitt lymphoma [47] and served as an
adequate control cell line in this study. The cells did not alter their
intracellular zinc concentrations during culture time. Therefore, the
observed changes of intracellular zinc levels in transformed B cells are
unlikely attributed to culture conditions.
This data together suggests that intracellular free zinc levels are
inﬂuenced by EBV-transformation/immortalization of B cells.3.2. Activated B cells show higher amounts of intracellular free zinc
To understand whether elevated zinc levels rely on the immortali-
zation or rather the activation of cells, the free zinc concentration in in
vitro activated B cells was determined in a subsequent experiment. To
generate these activated B cells in the absence of EBV, an in vitrocells.Measurements were performed in freshly isolated CD19+ PBMC before depletion
rence between the intracellular zinc concentration before and after T cell depletion was
A). The intracellular free zinc was repeatedly measured in LCL, starting at different time
levation of the zinc level would endure. Theﬁrst control was performedwith n=3, 20 to
r (B). The concentration of free intracellular zinc in Raji cells did not signiﬁcantly change
(C). Mean values + standard error of the mean (SEM) of n = 15 (A), n = 3 (B, C) are
5, repeated measurements ANOVA and Bonferroni's multiple comparison test for A and
r C).
Fig. 2. In vitro activation of B cells positively inﬂuences the level of free intracellular
zinc. Free intracellular zinc wasmeasured after dyeingwith FluoZin3-AM and CD19-PE.
Activated B cells were generated from PBMC through stimulation by tCD40L/NIH3T3
cells, IL-4 (50 U/mL) and CsA (0.63 µg/mL). After activation, CD19+ cells showed a
signiﬁcant higher level of free intracellular zinc. Presented is the mean + SEM of n= 7
(** p b 0.01; Student’s t-test).
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(CD40L) ligation and pathway induction was applied. In vivo, CD40L is
presented by activated T cells and ligation with CD40, a tumor necrosis
factor expressed by B cells, leads to activation of signaling pathways,
including protein tyrosine kinase activation [48]. PBMC were incubated
with murine tCD40L NIH/3 T3 cells in the presence of interleukin (IL)-4
and ciclosporin A (CsA) [38,39].
To assess the activation state, the expression level of the surface
marker and activation inducer molecule CD69 was determined. It is
expressed on activated lymphocytes, including LCL. After crosslinking,
CD69 is involved in the response of lymphocytes to various stimuli,
including the proliferative response. Resting B cells do not show CD69
surface expression [49,50]. Both, the CD40L-activated B cells (about
16.5% CD69+) and the cultured CD19+ LCL (about 50% CD69+),
showed high levels of CD69 on their surface, whereas this marker was
hardly expressed in non-activated PBMC (data not shown) [51,52].
The intracellular free zinc levels in CD40L-activated B cells were
comparably elevated to that of CD19+ LCL with a mean of 0.324 nM
(+ SEM 0.060 nM) (Fig. 2).
In summary, this data suggests activation or proliferation of B cells
as more likely factors for the observed increased zinc levels than
immortalization of B cells.Fig. 3. Expression of the activation marker CD69 is associated with a higher level of
free intracellular zinc in B cells. Measurements were performed in freshly isolated
CD19+ PBMC. Within those, CD69+ showed signiﬁcant higher intracellular zinc levels
than CD69- cells. Presented is the mean + SEM of n = 3 (* p b 0.05, Student’s t-test).3.3. Increased CD69 marker expression is associated with increased
intracellular zinc levels
So far, analyses were performed in EBV-immortalized and in vitro-
activated B cells. In the following experiment, the concentration of free
intracellular zinc and the expression of the activation marker CD69 in
freshly isolated CD19+ PBMC was determined. The zinc concentra-
tions in CD69+ and CD69- subpopulations were compared (Fig. 3) in
order to exclude other possible inﬂuencing factors associatedwith the
necessary treatment of B cells and the following culturing conditions.
The free intracellular zinc level in CD69+ B cells was enhanced,
comparable to the concentrations in LCL and activated B cells, while
the CD69- cells showed lower levels of free intracellular zinc.
3.4. Zinc transporter expression is changed in transformed and activated
human B cells
Since the levels of intracellular zinc were increased in transformed
B cells we further studied the expression of zinc transporters on RNA
levels to ﬁnd possible associated alterations (Fig. 4).
The relative RNA expression of various zinc transporterswas found to
be altered in the LCL compared to that of T cell depleted PBMC.
Expression of ZIP importers is shown in Fig. 4A and ZnT exporter
expression is presented in Fig. 4B. The lysosomotropic agent applied for
T cell depletion did not itself interfere with the RNA quantiﬁcation.
Hence, the treated PBMC could be used for normalization. The LCL
signiﬁcantly upregulated the zinc importers ZIP7 and ZIP14 (Fig. 4A) on
RNA levels compared to the T cell depleted PBMC, whereas the
expression of ZIP2, ZIP5 and ZIP12 (Fig. 4A) was signiﬁcantly reduced
as well as expression of ZnT6, ZnT9 and ZnT10 RNA (Fig. 4B). Variations
in expression levels are high due to the use of individual human samples.
Therefore, the expression of zinc transporters is not always signiﬁcant, as
one might expect, and indicated by the respective signiﬁcancies (Fig. 4).
To conﬁrm whether the altered expression was caused by
transformation or by culturing conditions, transporter expression
was also analyzed in Raji cell culture. A decrease of ZIP3 RNA could be
detected 24 h and 72 h after subculturing in fresh medium, whereas,
the expression of ZnT3 RNA was decreased 72 h after subculturing.
Although a signiﬁcant increase of RNA expression following time of
culture could not be detected, an impact of culturing conditions on the
expression of the mentioned transporters cannot be excluded (data
not shown).
Consistent with the ﬁndings on RNA levels in LCL, elevated levels of
ZIP7 on the protein levelwere found in both, LCL (Fig. 5A) and in in vitro
activated B cells (Fig. 5C). Furthermore, an increased phosphorylation of
ZIP7 protein (pZIP7) could be demonstrated in immortalized and in
CD40L-activated B cells (Fig. 5B, D).
4. Discussion
All in all, the data suggest that activation andproliferation of B cells,
rather than other factors like immortalization or long-time culturing,
is associated with increased intracellular zinc concentrations. High
proliferation rates are also a common characteristic of tumor cells.
Thus, it seems reasonable, that the highly proliferative CD69+ B cells
share some traits with the latter. Actually, alterations of zinc
transporters going along with increased zinc levels were previously
found in various solid cancer cells, e.g. in invasive breast carcinoma
[24] and malignant ovarian tumors [53]. Inconsistent studies indicate
at least an effect ofmalignancy on the zinc level in pancreatic cancer, as
they show either elevated [25] or decreased zinc levels [54]. Prostate
carcinoma cells have been well studied regarding their zinc homeo-
stasis and they are an outstanding exception. They downregulate their
ZIP4 expression [55] and show decreased concentrations of zinc [56].
This discrepancy to the behavior of other tumors might be due to the
Fig. 4. RNA expression of several zinc transporters is altered after EBV-transformation. The RNA expression in LCL was compared to T cell depleted PBMC. The ΔΔCT-method
was used for quantiﬁcation. Cycle 40 was set, when transporters were non-expressed before or after transformation. Shown is the relative expression of RNA after EBV-transformation
in comparisonwith the expression of RNA in T cell depleted PBMC, equaling a relative expression of 1, normalized to the housekeeping gene PBGD.Mean values+ SEMof n=9 (A) and
n = 7 (B) are shown (* p b 0.05, Student’s t-test).
Fig. 5. ZIP7 and phosphorylation of ZIP7 (pZIP7) are increased after immortalization and activation. Analysis of ZIP7 expression in LCL (A) and CD40L-activated B cells from freshly
isolated PBMC (C) showed increased ZIP7 protein levels compared to measurements in only T cell depleted PBMC or freshly isolated PBMC, respectively. Apart from that, not only
the amount of ZIP7 was increased, but also phosphorylation of the ZIP7 importer (B, D). (A-D) Densitometric quantiﬁcation of n=5 (A, B) and n=3 (C, D) is presented asmean+ SEM
(** p b 0.01, *** p b 0.001; Student’s t-test). (E) Immunodetection of one representative Western Blot.
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tissues with 1.018±0.124mg zinc/g dry tissue [57]. Numerous studies
also indicate an associationbetween the aberrant expressionof certain
zinc transporters and malignancy in tissue samples from cancers and
cell lines. The higher intracellular zinc levels might result from an
increased expression of zinc importers and serve a fast-growing tumor
cell to maintain sufﬁcient zinc for further proliferation [25]. The
observed changes in zinc homeostasis and transporter expression in
cancer cells and in LCL might have similar reasons and functions. LCLs
encode various viral products, amongst these the latent membrane
protein 1 (LMP1) [35]. LMP1 is an oncogene and seems tomimic CD40-
CD40L-interaction [58]. On the molecular level, both LMP1 and the
CD40-signaling activate the nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-κB) [59,60]. The activated NF-κB is
an important signaling molecule, especially in the immune system,
inducing several anti-apoptotic proteins, stimulating cell cycle
progression and playing a crucial role in carcinogenesis [61]. Its either
constitutive expression or over-expression was demonstrated in
various cancers, including solid and hematopoietic cancers [61].
Moreover, NF-κB induces the expression of CD69 [51], which is
expressed at the surface of activated, proliferating lymphocytes [62].
Activation and proliferation of B cells are crucial for a functional
immune system. Physiologically, B cells need the CD40-CD40L-
interaction in addition to further signals to become activated and to
start proliferation. CD40 is a B cell surface protein, while CD40L is
physiologically presented by activated T cells [63].
In the current study, we utilized CD40L-transfected murine
ﬁbroblasts in combination with IL-4 in the absence of T cells to
generate an adequate T cell independent growth signal for B cells [38].
Both, the LCL and the CD40L-activated B cells, expressed high levels of
CD69 on their surface. Within these cells, the level of free zinc was
found to be elevated. Levels of free zinc were also higher in freshly
isolated PBMC, expressing the surface markers CD19 and CD69,
compared to zinc levels found in CD19+andCD69- cells.We therefore
suggest an association between the expression of the CD69 activation
marker on the cell surface of CD19+ B cells and an elevated
intracellular zinc level. The elevated zinc levels observed in LCL and
CD40L-activated B cells in the present study are likely originating from
the endoplasmatic recticulum (ER) upon activation, due to the
detected increased amounts of ZIP7 increased phosphorylation of
ZIP7 after activation, which is especially found with the membrane of
the ER [64]. The elevated free zinc might serve as a co-stimulus for the
elevation of NF-κB due to LMP1 or CD40-signaling. Another explana-
tion might be that the NF-κB pathway leads to increased free
intracellular zinc by alternating the expression of zinc transporters
and thus gaining malignant cellular characteristics.
With respect to signaling pathways, zinc has already been shown
to stimulate proliferation via the PI3K/AKT cascade and/or ERK, e.g. in
T cells [18] and murine myogenic cells [19]. Both molecules, AKT and
ERK, are serine/threonine kinases. AKT is known to prevent apoptosis,
promote cell survival and seems to raise cell cycle progression by its
manifold downstream targets [65]. ERK is involved in the mitogen-
activated protein kinase (MAPK)/ERK pathway and stimulates cell
proliferation and survivalwhenphosphorylated [19,66]. These kinases
regulate the cell cycle via phosphorylation of downstream molecules.
Aberrations that affect these pathways, especially constitutive
activation, are known to be involved in the development of a wide
range of cancers [67]. We suggest a comparable upregulation of cell
cycle regulating pathways in CD69+ B cells, matching the observed
increase of free intracellular zinc.
Having demonstrated an increase of free intracellular zinc in the
activated and proliferating cells, we also showed an elevation of the RNA
level of zinc importers ZIP7andZIP14 inLCL. ZIP7protein is knowntoplay
an important role in zinc release and its phosphorylation activates
proliferation pathways in human cells [21]. There exist antibodies forboth, ZIP7 and phosphorylated ZIP7, therefore ZIP7 was chosen in this
study for closer analysis on protein levels. However, determination of
other transporter expression on protein levels might be interesting for
upcoming studies. An increase of ZIP7 proteinwas conﬁrmed in both, LCL
andCD40L-activatedBcells.Not onlywas the total amountofZIP7protein
increased after transformation, but also its phosphorylation, which
indicates increased activation of the transporter. The post-translational
phosphorylation of the ZIP7 transporter is proposed to be crucial for the
release of stored zinc and the generation of intracellular zinc waves [68].
ZIP7 protein is localized on inner membranes, such as the membrane of
the endoplasmic reticulum [15] and of the Golgi apparatus [69]. It enables
the release of stored zinc to prevent cytoplasmic zinc deﬁciency aswell as
an accumulation in the Golgi apparatus [69]. The increase of free zinc,
following a ZIP7-mediated zinc release, inhibits phosphatases and
therefore augments signaling by less deactivation and subsequent
accumulation of phosphorylated kinases such as ERK [64] and AKT [21].
An increase of both ZIP7 RNA and protein levels has been shown by
Taylor et al. in aggressive tamoxifen resistant breast cancer cells,
compared to the non-resistant cells, thereby demonstrating activation
of cancer promoting pathways by the increase of zinc, leading to
proliferation and aggressive growth [24].
Related observations of the signaling in physiological conditions
were made in chicken DT40 B cells. Here, ZIP9 led to zinc release from
intracellular stores after B cell receptor (BCR)-cross linking. Since
DT40 cells do not express ZIP7, ZIP9 might replace the functions that
ZIP7 fulﬁlls in human cells. The authors propose the zinc wave to
inhibit tyrosine phosphatases, e.g. by degradation or by binding to an
active site, and therefore to prevent deactivation of phosphorylated
ERK and AKT and to lead to prolonged signaling [70].
Furthermore, in the present study ZIP14 RNA was elevated in LCL.
ZIP14 overexpression has already been shown to increase the prolifer-
ation of hepatocytes in mice, again by phosphorylation of kinases [71].
Even though there are differences between breast cancer cells,
chicken B cells, proliferating hepatocytes and the studied B cells, some
similarities regarding the affected pathways can be suggested. Therefore,
we assume our ﬁndings to be part of the signaling pathways, including a
phosphorylation of kinases, to enable high proliferation and activation
rates of cells. The upregulation or increased activation of zinc importers
might explain the observed elevation of free intracellular zinc in in vitro
EBV-transformed B cells, which in turnmight lead to increased signaling
within the cells. These ﬁndings suggest upregulation of zinc importers,
particularly ZIP7 upregulation, as a commonphenomenon in B cellswith
a high proliferation rate, playing an important role in the signaling
activities of a cell.
Additionally, a decrease of RNA expression of the zinc importers
ZIP5 and ZIP12, but also of the zinc exporters ZnT6, ZnT9 and ZnT10
was found in the present study. The latter might ensure high
intracellular zinc levels due to lower zinc export.
In summary, signiﬁcantly elevated zinc levels have been shown in
activated B cells. Furthermore, in the LCL, elevated zinc levels are
accompanied by altered zinc transporter expression at the RNA level. A
relation between increased zinc levels and the highly expressed
activation marker CD69 has also been demonstrated. Moreover, not
only was there observed upregulation of ZIP7 RNA there was also
increased ZIP7 protein levels in LCL and CD40L-activated B cells, being
accompanied by increased ZIP7 phosphorylation, consistent with
active release of zinc from stores.
In conclusion, increased intracellular zinc seems to be a prerequisite
of B cell activation.Funding
The generation of the pZIP7 antibody was funded by a Wellcome
Trust University Research Award (091991/Z/10/Z) to KMT.
78 J. Ollig et al. / Journal of Nutritional Biochemistry 64 (2019) 72–79Acknowledgments
We thank Dr. Freeman for the kind gift of the adherent murine
ﬁbroblast CD40L-transformed NIH/3T3 cells.
K.T. and L.R. are members of Zinc-Net.
References
[1] Prasad AS, Miale Jr A, Farid Z, Sandstead HH, Schulert AR. Zinc metabolism in
patients with the syndrome of iron deficiency anemia, hepatosplenomegaly,
dwarfism, and hypognadism. J Lab Clin Med 1963;61:537–49.
[2] Haase H, Rink L. Zinc signals and immune function. Biofactors 2014;40:27–40.
[3] Maares M, Haase H. Zinc and immunity: an essential interrelation. Arch Biochem
Biophys 2016;611:58–65.
[4] Hojyo S, Fukada T. Roles of zinc signaling in the immune system. J Immunol Res
2016;2016:6762343.
[5] Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol
2012;30:221–41.
[6] King LE, Fraker PJ. Variations in the cell cycle status of lymphopoietic and
myelopoietic cells createdby zinc deficiency. J InfectDis 2000;182(Suppl. 1):S16–22.
[7] Wessels I, Maywald M, Rink L. Zinc as a gatekeeper of immune function. Nutrients
2017;9:e1286.
[8] Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev 1993;
73:79–118.
[9] Maret W. Molecular aspects of human cellular zinc homeostasis: redox control of
zinc potentials and zinc signals. Biometals 2009;22:149–57.
[10] Colvin RA, Holmes WR, Fontaine CP, Maret W. Cytosolic zinc buffering and
muffling: their role in intracellular zinc homeostasis. Metallomics 2010;2:306–17.
[11] Yamasaki S, Sakata-Sogawa K, Hasegawa A, Suzuki T, Kabu K, Sato E, et al. Zinc is a
novel intracellular second messenger. J Cell Biol 2007;177:637–45.
[12] Krezel A, Maret W. The biological inorganic chemistry of zinc ions. Arch Biochem
Biophys 2016;611:3–19.
[13] Krezel A, Maret W. Zinc-buffering capacity of a eukaryotic cell at physiological
pZn. J Biol Inorg Chem 2006;11:1049–62.
[14] Kambe T, Tsuji T, Hashimoto A, Itsumura N. The physiological, biochemical, and
molecular roles of zinc transporters in zinc homeostasis and metabolism. Physiol
Rev 2015;95:749–84.
[15] Kimura T, Kambe T. The functions of Metallothionein and ZIP and ZnT transporters:
an overview and perspective. Int J Mol Sci 2016;17:336.
[16] Fukada T, Kambe T. Molecular and genetic features of zinc transporters in
physiology and pathogenesis. Metallomics 2011;3:662–74.
[17] Lichten LA, Cousins RJ. Mammalian zinc transporters: nutritional and physiologic
regulation. Annu Rev Nutr 2009;29:153–76.
[18] Kaltenberg J, Plum LM, Ober-Blobaum JL, Honscheid A, Rink L, Haase H. Zinc
signals promote IL-2-dependent proliferation of T cells. Eur J Immunol 2010;40:
1496–503.
[19] Ohashi K, Nagata Y, Wada E, Zammit PS, Shiozuka M, Matsuda R. Zinc promotes
proliferation and activation of myogenic cells via the PI3K/Akt and ERK signaling
cascade. Exp Cell Res 2015;333:228–37.
[20] Kim YM, ReedW,WuW, Bromberg PA, Graves LM, Samet JM. Zn2+−induced IL-8
expression involves AP-1, JNK, and ERK activities in human airway epithelial cells.
Am J Physiol Lung Cell Mol Physiol 2006;290:L1028–35.
[21] Nimmanon T, Ziliotto S, Morris S, Flanagan L, Taylor KM. Phosphorylation of zinc
channel ZIP7 drives MAPK, PI3K and mTOR growth and proliferation signalling.
Metallomics 2017;9:471–81.
[22] De LucaA,MaielloMR,D'AlessioA, PergamenoM,NormannoN. TheRAS/RAF/MEK/ERK
and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for
therapeutic approaches. Expert Opin Ther Targets 2012;16(Suppl. 2):S17–27.
[23] Xu X, Guo HJ, Xie HY, Li J, Zhuang RZ, Ling Q, et al. ZIP4, a novel determinant of
tumor invasion in hepatocellular carcinoma, contributes to tumor recurrence
after liver transplantation. Int J Biol Sci 2014;10:245–56.
[24] Taylor KM, Vichova P, Jordan N, Hiscox S, Hendley R, Nicholson RI. ZIP7-mediated
intracellular zinc transport contributes to aberrant growth factor signaling in
antihormone-resistant breast cancer cells. Endocrinology 2008;149:4912–20.
[25] LiM, Zhang Y, Liu Z, BharadwajU,WangH,WangX, et al. Aberrant expression of zinc
transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer
pathogenesis and progression. Proc Natl Acad Sci U S A 2007;104:18636–41.
[26] Cooper G. The cell: A molecular approach. 2nd ed. Sunderland (MA): Sinauer
Associates; 2000.
[27] Stoian M, State N, Stoica V, Radulian G. Apoptosis in colorectal cancer. J Med Life
2014;7:160–4.
[28] Huber KL, Hardy JA. Mechanism of zinc-mediated inhibition of caspase-9. Protein
Sci 2012;21:1056–65.
[29] Stennicke HR, Salvesen GS. Biochemical characteristics of caspases-3,−6,−7, and−8.
J Biol Chem 1997;272:25719–23.
[30] Velazquez-Delgado EM, Hardy JA. Zinc-mediated allosteric inhibition of caspase-6.
J Biol Chem 2012;287:36000–11.
[31] Plum LM, Rink L, Haase H. The essential toxin: impact of zinc on human health. Int
J Environ Res Public Health 2010;7:1342–65.
[32] Treves S, Trentini PL, Ascanelli M, Bucci G, Di Virgilio F. Apoptosis is dependent on
intracellular zinc and independent of intracellular calcium in lymphocytes. Exp
Cell Res 1994;211:339–43.[33] Scholz A, Heinze S, Detjen KM, Peters M, Welzel M, Hauff P, et al. Activated signal
transducer and activator of transcription 3 (STAT3) supports the malignant
phenotype of human pancreatic cancer. Gastroenterology 2003;125:891–905.
[34] Zhang Y, Chen C, Yao Q, Li M. ZIP4 upregulates the expression of neuropilin-1,
vascular endothelial growth factor, and matrix metalloproteases in pancreatic
cancer cell lines and xenografts. Cancer Biol Ther 2010;9:236–42.
[35] Bornkamm GW, Hammerschmidt W. Molecular virology of Epstein-Barr virus.
Philos Trans R Soc Lond Ser B Biol Sci 2001;356:437–59.
[36] Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4:
757–68.
[37] Ohlin M, Danielsson L, Carlsson R, Borrebaeck CA. The effect of leucyl-leucine
methyl ester on proliferation and Ig secretion of EBV-transformed human B
lymphocytes. Immunology 1989;66:485–90.
[38] Naito M, Hainz U, Burkhardt UE, Fu B, Ahove D, Stevenson KE, et al. CD40L-tri, a
novel formulation of recombinant human CD40L that effectively activates B cells.
Cancer Immunol Immunother 2013;62:347–57.
[39] Liebig TM, Fiedler A, Zoghi S, Shimabukuro-Vornhagen A, von Bergwelt-Baildon
MS. Generation of human CD40-activated B cells. J Vis Exp 2009. https://doi.org/
10.3791/1373.
[40] Haase H, Ober-Blobaum JL, Engelhardt G, Hebel S, Heit A, Heine H, et al. Zinc
signals are essential for lipopolysaccharide-induced signal transduction in
monocytes. J Immunol 2008;181:6491–502.
[41] Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with
greatly improved fluorescence properties. J Biol Chem 1985;260:3440–50.
[42] Ibs K-H. Die Bedeutung von Zinkionen für mononucleäre Leukocyten [dissertation].
Aachen (Germany): RWTH; 2005.
[43] Leung KW, LiuM, Xu X, Seiler MJ, Barnstable CJ, Tombran-Tink J. Expression of ZnT
and ZIP zinc transporters in the human RPE and their regulation by neurotrophic
factors. Invest Ophthalmol Vis Sci 2008;49:1221–31.
[44] Overbeck S, Uciechowski P, Ackland ML, Ford D, Rink L. Intracellular zinc
homeostasis in leukocyte subsets is regulated by different expression of zinc
exporters ZnT-1 to ZnT-9. J Leukoc Biol 2008;83:368–80.
[45] Faneyte IF, Kristel PM, van de Vijver MJ. Determining MDR1/P-glycoprotein
expression in breast cancer. Int J Cancer 2001;93:114–22.
[46] Li X, Ding Y, Zi M, Sun L, Zhang W, Chen S, et al. CD19, from bench to bedside.
Immunol Lett 2017;183:86–95.
[47] Drexler HG, Minowada J. History and classification of human leukemia-lymphoma
cell lines. Leuk Lymphoma 1998;31:305–16.
[48] van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000;67:2–17.
[49] Marzio R, Mauel J, Betz-Corradin S. CD69 and regulation of the immune function.
Immunopharmacol Immunotoxicol 1999;21:565–82.
[50] Risso A, Cosulich ME, Rubartelli A, Mazza MR, Bargellesi A. MLR3 molecule is an
activation antigen shared by human B, T lymphocytes and T cell precursors. Eur J
Immunol 1989;19:323–8.
[51] Ishikawa C, Mori N. Epstein-Barr virus latent membrane protein 1 induces CD69
expression through activation of nuclear factor-kappaB. Int J Oncol 2013;42:
1786–92.
[52] Testi R, D'Ambrosio D, De Maria R, Santoni A. The CD69 receptor: a multipurpose
cell-surface trigger for hematopoietic cells. Immunol Today 1994;15:479–83.
[53] Lightman A, Brandes JM, Binur N, Drugan A, Zinder O. Use of the serum copper/zinc
ratio in the differential diagnosis of ovarian malignancy. Clin Chem 1986;32:101–3.
[54] Costello LC, Levy BA, Desouki MM, Zou J, Bagasra O, Johnson LA, et al. Decreased
zinc and downregulation of ZIP3 zinc uptake transporter in the development of
pancreatic adenocarcinoma. Cancer Biol Ther 2011;12:297–303.
[55] Chen QG, Zhang Z, Yang Q, Shan GY, Yu XY, Kong CZ. The role of zinc transporter
ZIP4 in prostate carcinoma. Urol Oncol 2012;30:906–11.
[56] Franz MC, Anderle P, Burzle M, Suzuki Y, Freeman MR, Hediger MA, et al. Zinc
transporters in prostate cancer. Mol Asp Med 2013;34:735–41.
[57] Zaichick V, Sviridova TV, Zaichick SV. Zinc in the human prostate gland: normal,
hyperplastic and cancerous. Int Urol Nephrol 1997;29:565–74.
[58] Kilger E, Kieser A, Baumann M, Hammerschmidt W. Epstein-Barr virus-mediated
B-cell proliferation is dependent upon latent membrane protein 1, which
simulates an activated CD40 receptor. EMBO J 1998;17:1700–9.
[59] Berberich I, Shu GL, Clark EA. Cross-linking CD40 on B cells rapidly activates
nuclear factor-kappa B. J Immunol 1994;153:4357–66.
[60] Dudziak D, Kieser A, Dirmeier U, Nimmerjahn F, Berchtold S, Steinkasserer A, et al.
Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB
signaling pathway. J Virol 2003;77:8290–8.
[61] Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-kB in development and
progression of human cancer. Virchows Arch 2005;446:475–82.
[62] Sanchez-Mateos P, Cebrian M, Acevedo A, Lopez-Botet M, De Landazuri MO,
Sanchez-Madrid F. Expression of a gp33/27,000 MW activation inducer molecule
(AIM) on human lymphoid tissues. Induction of Cell Proliferation on thymocytes
and B lymphocytes by anti-AIM Antibodies. Immunology 1989;68:72–9.
[63] Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, et al. The
CD40 antigen and its ligand. Annu Rev Immunol 1994;12:881–922.
[64] Hogstrand C, Kille P, Nicholson RI, Taylor KM. Zinc transporters and cancer: a
potential role for ZIP7 as a hub for tyrosine kinase activation. Trends Mol Med
2009;15:101–11.
[65] Kandel ES, Hay N. The regulation and activities of the multifunctional serine/
threonine kinase Akt/PKB. Exp Cell Res 1999;253:210–29.
[66] Burotto M, Chiou VL, Lee JM, Kohn EC. The MAPK pathway across different
malignancies: a new perspective. Cancer 2014;120:3446–56.
[67] Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in
human malignancy. Cell Signal 2002;14:381–95.
79J. Ollig et al. / Journal of Nutritional Biochemistry 64 (2019) 72–79[68] Taylor KM, Hiscox S, Nicholson RI, Hogstrand C, Kille P. Protein kinase CK2 triggers
cytosolic zinc signaling pathways by phosphorylation of zinc channel ZIP7. Sci
Signal 2012;5:ra11.
[69] Huang L, Kirschke CP, Zhang Y, Yu YY. The ZIP7 gene (Slc39a7) encodes a zinc
transporter involved in zinc homeostasis of the Golgi apparatus. J Biol Chem 2005;
280:15456–63.[70] TaniguchiM, Fukunaka A, HagiharaM,Watanabe K, Kamino S, Kambe T, et al. Essential
role of the zinc transporter ZIP9/SLC39A9 in regulating the activations of Akt and Erk in
B-cell receptor signaling pathway in DT40 cells. PLoS One 2013;8:e58022.
[71] Aydemir TB, Sitren HS, Cousins RJ. The zinc transporter Zip14 influences c-Met
phosphorylation and hepatocyte proliferation during liver regeneration in mice.
Gastroenterology 2012;142:1536–1546.e5.
